Global Molecular Breeding Market to Reach $27.7 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.


New York, May 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Breeding Industry" - https://www.reportlinker.com/p06032264/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Molecular Breeding Market to Reach $27.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Molecular Breeding estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$27.7 Billion by 2030, growing at aCAGR of 19.8% over the period 2022-2030. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$10.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the QTL Mapping segment is readjusted to a revised 19.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 18.7% CAGR

The Molecular Breeding market in the U.S. is estimated at US$1.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2030 trailing a CAGR of 18.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.4% and 16.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Select Competitors (Total 32 Featured)
- Eurofins Scientific
- Illumina
- LGC Limited
- Thermo Fisher Scientific, Inc.
- SGS SA
- DanBred
- Intertek Group Plc
- LemnaTec GmbH
- Charles River Laboratories
- Slipstream Automation
- Fruitbreedomics


Read the full report: https://www.reportlinker.com/p06032264/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Molecular Breeding - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Molecular Breeding by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for Molecular Breeding by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Molecular Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Marker-Assisted Selection (MAS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Marker-Assisted Selection
(MAS) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Marker-Assisted
Selection (MAS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for QTL
Mapping by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for QTL Mapping by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for QTL Mapping by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Marker-Assisted Backcrossing (MABC) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Marker-Assisted
Backcrossing (MABC) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Marker-Assisted
Backcrossing (MABC) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Genomic Selection by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Genomic Selection by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Genomic Selection by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Other Processes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Other Processes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Other Processes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Single Nucleotide Polymorphism (SNP) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Single Nucleotide
Polymorphism (SNP) by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Single Nucleotide
Polymorphism (SNP) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Simple Sequence Repeats (SSR) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Simple Sequence Repeats
(SSR) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Simple Sequence Repeats
(SSR) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for Crop
Breeding by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 26: World Historic Review for Crop Breeding by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 27: World 16-Year Perspective for Crop Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Livestock by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 29: World Historic Review for Livestock by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Livestock by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 31: World Molecular Breeding Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 32: USA Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 33: USA Historic Review for Molecular Breeding by Process -
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 34: USA 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 35: USA Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 36: USA Historic Review for Molecular Breeding by Marker -
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 37: USA 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 38: USA Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 40: USA 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

CANADA
Table 41: Canada Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 42: Canada Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 43: Canada 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 44: Canada Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 45: Canada Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 46: Canada 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 47: Canada Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 48: Canada Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 49: Canada 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

JAPAN
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 50: Japan Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 51: Japan Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 52: Japan 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 53: Japan Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 54: Japan Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 55: Japan 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 56: Japan Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 57: Japan Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 58: Japan 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

CHINA
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 59: China Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 60: China Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 61: China 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 63: China Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 64: China 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 65: China Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 66: China Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 67: China 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

EUROPE
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 68: Europe Recent Past, Current & Future Analysis for
Molecular Breeding by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 69: Europe Historic Review for Molecular Breeding by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 70: Europe 16-Year Perspective for Molecular Breeding by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 72: Europe Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 73: Europe 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 75: Europe Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 79: Europe 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

FRANCE
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 80: France Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 81: France Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 82: France 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 83: France Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 84: France Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 85: France 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 86: France Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 87: France Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 88: France 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

GERMANY
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 89: Germany Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 90: Germany Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 91: Germany 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 93: Germany Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 94: Germany 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 95: Germany Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 96: Germany Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 97: Germany 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

ITALY
Table 98: Italy Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 99: Italy Historic Review for Molecular Breeding by
Process - Marker-Assisted Selection (MAS), QTL Mapping,
Marker-Assisted Backcrossing (MABC), Genomic Selection and
Other Processes Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2014 through 2021 and % CAGR

Table 100: Italy 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 101: Italy Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 102: Italy Historic Review for Molecular Breeding by
Marker - Single Nucleotide Polymorphism (SNP) and Simple
Sequence Repeats (SSR) Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 103: Italy 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 104: Italy Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 105: Italy Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 106: Italy 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

UNITED KINGDOM
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 107: UK Recent Past, Current & Future Analysis for
Molecular Breeding by Process - Marker-Assisted Selection
(MAS), QTL Mapping, Marker-Assisted Backcrossing (MABC),
Genomic Selection and Other Processes - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 108: UK Historic Review for Molecular Breeding by Process -
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 109: UK 16-Year Perspective for Molecular Breeding by
Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 110: UK Recent Past, Current & Future Analysis for
Molecular Breeding by Marker - Single Nucleotide Polymorphism
(SNP) and Simple Sequence Repeats (SSR) - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 111: UK Historic Review for Molecular Breeding by Marker -
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 112: UK 16-Year Perspective for Molecular Breeding by
Marker - Percentage Breakdown of Value Sales for Single
Nucleotide Polymorphism (SNP) and Simple Sequence Repeats (SSR)
for the Years 2014, 2023 & 2030

Table 113: UK Recent Past, Current & Future Analysis for
Molecular Breeding by Application - Crop Breeding and Livestock -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Molecular Breeding by
Application - Crop Breeding and Livestock Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 115: UK 16-Year Perspective for Molecular Breeding by
Application - Percentage Breakdown of Value Sales for Crop
Breeding and Livestock for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Molecular Breeding by Process - Marker-Assisted
Selection (MAS), QTL Mapping, Marker-Assisted Backcrossing
(MABC), Genomic Selection and Other Processes - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 117: Rest of Europe Historic Review for Molecular
Breeding by Process - Marker-Assisted Selection (MAS), QTL
Mapping, Marker-Assisted Backcrossing (MABC), Genomic Selection
and Other Processes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 118: Rest of Europe 16-Year Perspective for Molecular
Breeding by Process - Percentage Breakdown of Value Sales for
Marker-Assisted Selection (MAS), QTL Mapping, Marker-Assisted
Backcrossing (MABC), Genomic Selection and Other Processes for
the Years 2014, 2023 & 2030

Table 119: Rest of Europe Recent Past, Current & Future
Analysis for Molecular Breeding by Marker - Single Nucleotide
Polymorphism (SNP) and Simple Sequence Repeats (SSR) -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 120: Rest of Europe Historic Review for Molecular
Breeding by Marker - Single Nucleotide Polymorphism (SNP) and
Simple Sequence Repeats (SSR) Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 121: Rest of Europe 16-Year Perspective for Molecular
Breeding by Marker - Percentage Breakdown of Value Sales for
Single Nucleotide Polymorphism (SNP) and Simple Sequence
Repeats (SSR) for the Years 2014, 2023 & 2030

Table 122: Rest of Europe Recent Past, Current & Future
Analysis for Molecular Breeding by Application - Crop Breeding
and Livestock - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 123: Rest of Europe Historic Review for Molecular
Breeding by Application - Crop Breeding and Livestock Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 124: Rest of Europe 16-Year Perspective for Molecular
Breeding by Application - Percentage Breakdown of Value Sales
for Crop Breeding and Livestock for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Molecular Breeding Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032264/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

Contact Data

GlobeNewswire